TP53 and neoplasm: In the vast majority of human neoplasia, including colorectal cancer (CRC), deregulation of the p53 pathway usually occurs by direct inactivation of the TP53 gene itself; this occurs mainly via point mutations [5], which usually increase the stability of the mutant p53 protein, leading to its overexpression [6].